AUS
NZ
UK
CA
USA
IND
What’s Behind SciDev’s Revised Outlook and Profit Growth?
SciDev adjusts revenue outlook amid external challenges while maintaining steady profit growth, highlighting operational resilience and shifting project timelines within the evolving industrial solutions market.
- April 20, 2026 02:43 PM AEST
- Sam
ASX 200 Lunch Wrap as CHESS Update Shapes Market
ASX market activity reflects CHESS system updates and energy sector developments, highlighting sector participation across ASX 200 and All Ordinaries indices.
- April 20, 2026 02:42 PM AEST
- Sam
Hidden ASX AI Stocks Quietly Building Momentum
Emerging ASX AI stocks like Macquarie Technology, Objective, and Appen highlight growing opportunities across infrastructure, software, and data in the expanding artificial intelligence sector.
- April 20, 2026 02:41 PM AEST
- Sam
Myer Valuation Debate: Cheap Retail Stock or Structural Challenge?
Myer faces earnings pressure amid retail challenges, but valuation discussions and strategic initiatives continue to shape its outlook within the ASX retail stocks segment.
- April 20, 2026 02:37 PM AEST
- Sam
Can Janus Electric Drive the Future of Truck Electrification?
Janus Electric expands globally with its truck electrification strategy, leveraging incentives and rising demand for sustainable transport solutions.
- April 20, 2026 02:36 PM AEST
- Sam
Bioxyne Earnings Growth Sparks Interest in Cannabis Sector
Bioxyne’s earnings growth and insider confidence highlight improving momentum, positioning it as a notable company within the evolving ASX cannabis stock sector.
- April 20, 2026 02:32 PM AEST
- Sam
Midcap Momentum Builds as ASX Index Holds Steady Gains
ASX mid cap stocks continue to gain traction as the Midcap Index reflects stable growth, sector diversity, and balanced performance within the broader market.
- April 20, 2026 02:24 PM AEST
- Sam
Could This New Platform Redefine Global Clinical Trials?
Emyria launches a global clinical platform to connect drug sponsors with scalable infrastructure, aiming to accelerate complex therapy trials and improve patient access worldwide.
- April 20, 2026 02:24 PM AEST
- Sam
Blue-Chip ASX 200 Picks in Focus After Market Pullback
Blue-chip ASX stocks like REA Group and Breville are drawing attention as investors focus on quality, stability, and long-term growth opportunities after recent market shifts.
- April 20, 2026 02:18 PM AEST
- Sam
Uranium Sector Focus Highlights Atomic Eagle (ASX:AEU) Move
Atomic Eagle strengthens its leadership with uranium expertise, highlighting exploration activity and mining sector participation within the All Ordinaries market.
- April 20, 2026 02:17 PM AEST
- Sam